Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
This kit is developed for determining the percentage of human mature lymphocyte subtypes, T cells, B cells, NK cells, T helper/inducer and T suppressor/cytotoxic cell subsets in human whole blood or/and cryopreserved PBMCs by flow cytometry.
It is for research use only.
Flow cytometry has become the technology of choice for the monitoring of immune cells as it provides the possibility to analyze a large number of parameters simultaneously, in a short time and for a reasonable cost.
Assay Type | FACS |
Analyte | mature lymphocyte subtypes, T cells, B cells, NK cells, T helper/inducer cell subsets, T suppressor/cytotoxic cell subsets |
Format | 50T |
Reactivity | Human |
Regulatory Status | RUO |
Assay Time | 15min |
Recommended events | 2×10⁴-1×10⁶ cells |
Suitable Sample Type | Human PBMC |
Marker | Antibody | Isotype |
CD3-FITC | FABm001-03 | DNP-FM487 |
CD4-PE-CY7 | FABm002-04 | FABm008-04 |
CD8-APC-CY7 | FABm003-05 | FABm008-05 |
CD16-PE | FABm005-01 | DNP-PM1 |
CD19-APC | FABm004-02 | DNP-AFM487 |
CD45-Percp-Cy5.5 | FABm007-06 | FABm009-06 |
CD56-PE | FABm006-01 | DNP-PM486 |
Opened kit and reconstituted reagent should be stored at 2-8 °C and the shelf life is 30 days from the date of opening.
TBNK cells gating logical and PBMC cell analysis: Set the CD45/SSC scatter plot to identify the CD45+ lymphocyte cell population (A). CD45+ as lymphocyte cell population, select the CD45+ gate, set the CD3/SSC scatter plot to identify the CD3+ T cell population (B). The CD3/CD4 scatter diagram the Th gate to identify the CD3+CD4+ helper T cell population (C). The CD3/CD8 scatter diagram Tc gate to identify the CD3+CD8+ toxic T cell population (D). The CD3/CD19 scatter diagram B gate to identify the CD3-CD19+ B cell population (E). At last the CD3/CD16+CD56 scatter plot was set to acess the CD3-CD56+CD16+ NK cell population (F).
Emerging VoCs, Omicron, Delta, Beta, Alpha mutants and so on, including RBD, S trimer, S1, NTD, NP, etc. These mutants are of high purity and bioactivity and can be used to evaluate the efficacy of the antibodies and vaccination.
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2, CD133, GPRC5D,CCR8, CCR5, etc.
CD3 proteins and a collection of for bispecific antibody development which are of high specificity and bioactivities and suitable for immunization, antibody screening.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
The MABSOL biotinylated protein collection includes more than a hundred commonly studied drug targets and biomarker proteins.
Comprehensive cytokines including IL families, growth factors, chemokines, TNFs, etc. These products are HEK293 expressed and nearly in authentic structure, high purity and bioactivity, cell based assay/SPR/BLI verified.
To support preclinical/clinical immunogenicity and PK analysis, ACROBiosystems has developed a series of high-affinity anti-idiotypic antibodies. Our pipeline covers five hot targets including adalimum*b, rituxim*b, cetuxim*b, trastuzum*b, and bevacizum*b.
English Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|
English Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|
This web search service is supported by Google Inc.